Loading
Latest filing published 23 Jan 2025 for NAVCO Pharmaceuticals Inc. (formerly, BMGB Capital Corp.), €904.
No signal scores available.
Christopher Cooper discloses dealings in NAVCO Pharmaceuticals Inc. (formerly, BMGB Capital Corp.) to SEDI. The record holds 2 filings, for trades running from 13 April 2023 to 22 January 2025.
Every open-market trade on record is a sale: 1 sale worth €904. 2025 to date brings no purchases and 1 sale.
The newest entry dates from 23 January 2025: an open-market sale of €904, in NAVCO Pharmaceuticals Inc. (formerly, BMGB Capital Corp.). Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations